Max Healthcare Soars 2% on Pune Hospital Plan; Goldman Sachs Recommends 'Buy'

• Max Healthcare stock climbed over 2%, becoming a top Nifty gainer, trading around ₹1072 on NSE.
• The surge follows the announcement of a new 450-bed super-specialty hospital in Yerwada, Pune, with a ₹1000 crore investment, expected in 3 years.
• Chairman Abhay Soi emphasized Pune's growth and the strategic importance of this expansion for Max Healthcare.
• GOLDMAN SACHS issued a 'buy' recommendation for Max Healthcare, setting a target price of ₹1,325, citing the Pune entry as a significant positive.
• Despite short-term dips, the stock has delivered a 152.83% return over 3 years.

Why It Matters: Max Healthcare gains on Pune expansion news and Goldman Sachs 'buy' rating, signaling strategic growth.